Shareholder alert: investigation of avidity (rna) announced by holzer & holzer, llc

Atlanta, georgia--(newsfile corp. - september 29, 2022) - holzer & holzer, llc is investigating whether avidity biosciences, inc. ("avidity" or the "company") (nasdaq: rna) complied with federal securities laws. on september 27, 2022, avidity announced that the u.s. food and drug administration has placed a partial clinical hold on new participant enrollment in its phase 1/2 marina clinical trial following a serious adverse event. after this announcement, the company's stock price dropped.
RNA Ratings Summary
RNA Quant Ranking